SFC
GILD icon

SYM Financial Corp’s Gilead Sciences GILD Stock Holding History

SYM Financial Corp’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Sell
3,465
-85
-2% -$11.2K 0.04% 175
2026
Q1 		$495K Buy
3,550
+166
+5% +$23.2K 0.05% 132
2025
Q4 		$415K Buy
3,384
+144
+4% +$17.5K 0.04% 156
2025
Q3 		$360K Buy
3,240
+23
+0.7% +$2.61K 0.04% 172
2025
Q2 		$357K Buy
3,217
+1,318
+69% +$140K 0.04% 172
2025
Q1 		$213K Buy
+1,899
New +$196K 0.03% 251

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SYM Financial Corp's GILD Position: Q2 2026 in Review

SYM Financial Corp reduced its Gilead Sciences (GILD) stake by 2.4% in Q2 2026, selling an estimated $11.2K and leaving 3,465 shares worth $438K. The position accounts for 0.04% of the portfolio, ranked #175.

SYM Financial Corp first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $495K in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • SYM Financial Corp held 3,465 shares of Gilead Sciences worth $438K as of Q2 2026.
  • SYM Financial Corp sold 85 Gilead Sciences shares in Q2 2026, an estimated $11.2K.
  • Gilead Sciences made up 0.04% of SYM Financial Corp's portfolio in Q2 2026, its #175 holding.
  • SYM Financial Corp first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • SYM Financial Corp's Gilead Sciences position peaked at $495K in Q1 2026.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on SYM Financial Corp's 13F filing for Q2 2026, filed 4 Aug 2026.